Changes in LBM by baseline characteristics of patients
ONCOLOGY
The changes in LBM by various baseline characteristics are shown in Figure Subgroup analysis of changes in LBM at 12 weeks according to sex, age, Alb, albumin; BMI, BW loss within 6 months, ECOG PS, and concomitant anticancer therapy. BMI, body mass index; BW, body weight; CI, confidence interval; CRP, C‐reactive protein; ECOG PS, Eastern Cooperative Oncology Group Performance Status; EGFR‐TKI, epidermal growth factor receptor tyrosine kinase inhibitor; LBM, lean body weight; LS, least‐squares; OR, odds ratio.